Comparing the cost-effectiveness of different standardized tuberculosis treatment regimens in settings with varying prevalence of drug-resistant tuberculosis
Background: There is a growing need to identify appropriate standardized treatment strategies that will adequately treat drug-resistant TB (DR-TB) and prevent multidrug-resistant TB (MDR-TB). Methods: We built a Markov model comparing treatment-related morbidities, mortality and costs in Ecuador, Br...
Main Author: | Law, Yuen Shan |
---|---|
Other Authors: | Andrea Benedetti (Supervisor2) |
Format: | Others |
Language: | en |
Published: |
McGill University
2011
|
Subjects: | |
Online Access: | http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=96907 |
Similar Items
-
Prevalence of drug-resistant tuberculosis and associated factors
by: George Jó Bezerra Sousa, et al.
Published: (2021-08-01) -
Outcomes associated with standardized treatment regimens for extensively drug-resistant tuberculosis
by: Anivita Aggarwal, et al.
Published: (2020-01-01) -
Prevalence of Drug-Resistant Tuberculosis in Sudan: A Systematic Review and Meta-Analysis
by: Khalid Hajissa, et al.
Published: (2021-07-01) -
Cost-effectiveness of adding bedaquiline to drug regimens for the treatment of multidrug-resistant tuberculosis in the UK.
by: Lara J Wolfson, et al.
Published: (2015-01-01) -
Long term follow-up of drug resistant and drug susceptible tuberculosis contacts in a Low incidence setting
by: Johnston James, et al.
Published: (2012-10-01)